| pubmed-article:6969207 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6969207 | lifeskim:mentions | umls-concept:C0010346 | lld:lifeskim |
| pubmed-article:6969207 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:6969207 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:6969207 | lifeskim:mentions | umls-concept:C0027778 | lld:lifeskim |
| pubmed-article:6969207 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:6969207 | pubmed:dateCreated | 1981-2-24 | lld:pubmed |
| pubmed-article:6969207 | pubmed:abstractText | A group of 310 unrelated patients suffering from Crohn's disease has been screened for quantitative and electrophoretic variations of alpha 1-antitrypsin (alpha 1AT). A comparison was made betweeen patients and healthy controls. The distribution of electrophoretic alpha 1AT variants in the patients showed no significant deviation from the controls. The alpha 1AT quantities are significantly higher in the Crohn's disease population than in the controls. | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6969207 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6969207 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6969207 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6969207 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6969207 | pubmed:issn | 0017-5749 | lld:pubmed |
| pubmed-article:6969207 | pubmed:author | pubmed-author:KlasenE CEC | lld:pubmed |
| pubmed-article:6969207 | pubmed:author | pubmed-author:WetermanI TIT | lld:pubmed |
| pubmed-article:6969207 | pubmed:author | pubmed-author:BiemondII | lld:pubmed |
| pubmed-article:6969207 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6969207 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:6969207 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6969207 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6969207 | pubmed:pagination | 840-2 | lld:pubmed |
| pubmed-article:6969207 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:meshHeading | pubmed-meshheading:6969207-... | lld:pubmed |
| pubmed-article:6969207 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:6969207 | pubmed:articleTitle | alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands. | lld:pubmed |
| pubmed-article:6969207 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6969207 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6969207 | lld:pubmed |
